Skip to main content
. 2017 Jan 4;2017(1):CD004561. doi: 10.1002/14651858.CD004561.pub3

GF‐GS 01.

Trial name or title GF‐GS 01/NCT00144898
Methods Study design: RCT
Country: France
Participants Inclusion criteria: women aged 18‐90 years with clinically node‐negative operable unifocal N0 breast cancer (clinical tumour size < 30 mm)
Exclusion criteria: none listed
Interventions ALND vs SLN resection
Outcomes Recurrence‐free survival
Starting date 2003
Contact information Alain LEIZOROVICZ, Université Claude Bernard Lyon I (responsible party), Gilles Houvenaeghel, Institut Paoli Calmette (principal investigator)
Notes